764 related articles for article (PubMed ID: 25875837)
1. Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.
Morita M; Mii A; Shimizu A; Yasuda F; Shoji J; Masuda Y; Ohashi R; Nagahama K; Kaneko T; Tsuruoka S
PLoS One; 2015; 10(4):e0116700. PubMed ID: 25875837
[TBL] [Abstract][Full Text] [Related]
2. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases.
He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM
BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882
[TBL] [Abstract][Full Text] [Related]
3. Nature of progressive glomerulosclerosis in human membranous nephropathy.
Lee HS; Koh HI
Clin Nephrol; 1993 Jan; 39(1):7-16. PubMed ID: 8428410
[TBL] [Abstract][Full Text] [Related]
4. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
Cheng P; Xie Q; Liu S; Liu X; Wang L; Hao CM
Rev Assoc Med Bras (1992); 2024; 70(4):e20230871. PubMed ID: 38716932
[TBL] [Abstract][Full Text] [Related]
5. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.
Taneda S; Honda K; Ohno M; Uchida K; Nitta K; Oda H
Virchows Arch; 2015 Oct; 467(4):449-58. PubMed ID: 26266776
[TBL] [Abstract][Full Text] [Related]
6. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
7. Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.
Hara S; Kobayashi N; Sakamoto K; Ueno T; Manabe S; Takashima Y; Hamada J; Pastan I; Fukamizu A; Matsusaka T; Nagata M
Am J Pathol; 2015 Aug; 185(8):2118-31. PubMed ID: 26072030
[TBL] [Abstract][Full Text] [Related]
8. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation.
Hill GS; Heudes D; Bariéty J
Kidney Int; 2003 Mar; 63(3):1027-36. PubMed ID: 12631084
[TBL] [Abstract][Full Text] [Related]
9. Glomerular hypertrophy in preeclamptic patients with focal segmental glomerulosclerosis. A morphometric analysis.
Nishimoto K; Shiiki H; Nishino T; Kimura T; Sasaki Y; Yamasaki M; Morikawa H; Fujimoto S; Dohi K
Clin Nephrol; 1999 Apr; 51(4):209-19. PubMed ID: 10230553
[TBL] [Abstract][Full Text] [Related]
10. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
11. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological features of idiopathic membranous nephropathy with focal segmental sclerosis.
Li J; Chen B; Gao C; Huang J; Wang Y; Zhang S; Xu Y; Guo W; Wang R
BMC Nephrol; 2019 Dec; 20(1):467. PubMed ID: 31842785
[TBL] [Abstract][Full Text] [Related]
13. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
[TBL] [Abstract][Full Text] [Related]
14. [Two cases of idiopathic membranous nephropathy with focal and segmental glomerulosclerotic lesions in which renal function progressively deteriorated].
Suzuki R; Morita H; Mizobuchi M; Nemoto T; Sato Y; Niikura K; Ideura T; Yoshimura A
Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):381-7. PubMed ID: 10998919
[TBL] [Abstract][Full Text] [Related]
15. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.
Schwartz MM
Ren Fail; 2000 Nov; 22(6):663-84. PubMed ID: 11104157
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
Lee HS
Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
[TBL] [Abstract][Full Text] [Related]
17. Cellular focal segmental glomerulosclerosis: Clinical and pathologic features.
Stokes MB; Valeri AM; Markowitz GS; D'Agati VD
Kidney Int; 2006 Nov; 70(10):1783-92. PubMed ID: 17021605
[TBL] [Abstract][Full Text] [Related]
18. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.
Zhong J; Whitman JB; Yang HC; Fogo AB
J Histochem Cytochem; 2019 Sep; 67(9):623-632. PubMed ID: 31116068
[TBL] [Abstract][Full Text] [Related]
20. Two different pathways of glomerular enlargement in adults with focal and segmental glomerulosclerosis: a morphometric study.
Matsumae T; Fukuzaki M; Takebayashi S; Naito S
Am J Nephrol; 1998; 18(1):21-7. PubMed ID: 9481435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
